We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Good news is here, investing friends! Q3 earnings results are not only clear and present, but results are better than expected among most household name stocks ahead of the bell this morning. In a quarter rife with stresses from the nation’s capital, natural disasters both here and abroad, and other stock market headwinds, stronger-than-expected earnings are providing a good tonic for us this morning.
Goldman Sachs (GS - Free Report) tore the cover off the ball, figuratively speaking. The Wall Street investment giant easily surpassed top and bottom-line estimates: $5.02 per share beat the $4.31 expected, and revenues of $8.3 billion topped the $7.6 billion in the Zacks consensus estimate. This was also higher than the $8.2 billion recorded in the year-ago quarter. This marks the fourth quarter in the last five that Goldman Sachs has beaten earnings estimates, for a 4-quarter trailing average of 11.6%.
Morgan Stanley (MS - Free Report) also beat expectations for both earnings and revenues: the investment bank’s top line brought in $9.2 billion, versus the $9.0 billion expected, on earnings per share of 93 cents — easily outpacing the 81 cents anticipated. Investment banking revenues, in particular, grew 18.4% in the company’s Q3.
Household products giant Johnson & Johnson (JNJ - Free Report) beat earnings estimates by a solid dime to $1.90 per share, as top-line results also came in above expectations: $19.65 billion versus $19.28 billion in the Zacks consensus. Guidance for fiscal 2017 was also raised. Pharma sales in the quarter grew an impressive 15.4%.
For its fifth straight earnings beat (at least), United Healthcare (UNH - Free Report) also posted a positive surprise ahead of today’s opening bell: $2.66 per share bested the $2.57 expected. Revenues of $50.3 billion in the quarter rose 8.7% year over year on growth in medical enrollment.
On the other side of the street, Harley Davidson (HOG - Free Report) illustrated some of the difficulties in today’s market, just meeting the 40 cents per share expected in the Zacks consensus, down 40% from year-ago results. Sales of $962.1 million did top the $960.8 million expected, but these numbers are both down from the $1.1 billion reported in Q3 2016. Baby boomers buying fewer bikes looks to be the culprit here; in related news, Peter Fonda is 77 years old.
New Import/Export Numbers
September results for both import and export prices beat expectations this morning, up 0.7% last month from the 0.6% consensus, as well as the unrevised headline from the previous month. Exports performed even better, up 0.8% as opposed to the +0.5% expected. Imports year over year are in-line at +1.9%, while exports are +2.7% since this time last year. More grist for the interest rate hike mill. You know the Fed is paying attention to this.
???It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7% and +90.2%, respectively.
???And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Q3 Earnings Blasting Off: GS, MS, JNJ and More
Tuesday, October 17, 2017
Good news is here, investing friends! Q3 earnings results are not only clear and present, but results are better than expected among most household name stocks ahead of the bell this morning. In a quarter rife with stresses from the nation’s capital, natural disasters both here and abroad, and other stock market headwinds, stronger-than-expected earnings are providing a good tonic for us this morning.
Goldman Sachs (GS - Free Report) tore the cover off the ball, figuratively speaking. The Wall Street investment giant easily surpassed top and bottom-line estimates: $5.02 per share beat the $4.31 expected, and revenues of $8.3 billion topped the $7.6 billion in the Zacks consensus estimate. This was also higher than the $8.2 billion recorded in the year-ago quarter. This marks the fourth quarter in the last five that Goldman Sachs has beaten earnings estimates, for a 4-quarter trailing average of 11.6%.
Morgan Stanley (MS - Free Report) also beat expectations for both earnings and revenues: the investment bank’s top line brought in $9.2 billion, versus the $9.0 billion expected, on earnings per share of 93 cents — easily outpacing the 81 cents anticipated. Investment banking revenues, in particular, grew 18.4% in the company’s Q3.
Household products giant Johnson & Johnson (JNJ - Free Report) beat earnings estimates by a solid dime to $1.90 per share, as top-line results also came in above expectations: $19.65 billion versus $19.28 billion in the Zacks consensus. Guidance for fiscal 2017 was also raised. Pharma sales in the quarter grew an impressive 15.4%.
For its fifth straight earnings beat (at least), United Healthcare (UNH - Free Report) also posted a positive surprise ahead of today’s opening bell: $2.66 per share bested the $2.57 expected. Revenues of $50.3 billion in the quarter rose 8.7% year over year on growth in medical enrollment.
On the other side of the street, Harley Davidson (HOG - Free Report) illustrated some of the difficulties in today’s market, just meeting the 40 cents per share expected in the Zacks consensus, down 40% from year-ago results. Sales of $962.1 million did top the $960.8 million expected, but these numbers are both down from the $1.1 billion reported in Q3 2016. Baby boomers buying fewer bikes looks to be the culprit here; in related news, Peter Fonda is 77 years old.
New Import/Export Numbers
September results for both import and export prices beat expectations this morning, up 0.7% last month from the 0.6% consensus, as well as the unrevised headline from the previous month. Exports performed even better, up 0.8% as opposed to the +0.5% expected. Imports year over year are in-line at +1.9%, while exports are +2.7% since this time last year. More grist for the interest rate hike mill. You know the Fed is paying attention to this.
Mark Vickery
Senior Editor
Questions or comments about this article and/or its author? Click here>>
Today's Stocks from Zacks' Hottest Strategies
???It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7% and +90.2%, respectively.
???And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>